Contribution of Essential Oils to the Fight against Microbial Biofilms—A Review Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Bacterial Vaginosis
Bacterial Vaginosis
Bacterial vaginosis (BV) is caused by an imbalance in the vaginal microbiota, where the typically dominant Lactobacillus species are significantly reduced, leading to an overgrowth of anaerobic and facultative bacteria.
-
Divine Aleru
Researched by:
-
Divine Aleru
ID
Divine Aleru
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was reviewed?
The review paper focuses on the contribution of essential oils (EOs) in combating microbial biofilms, with an emphasis on their antimicrobial properties and the potential application in medical, food, and other industrial sectors. The review explores the growing body of scientific data showing the effectiveness of essential oils against biofilms, which are known to contribute to persistent infections, particularly those associated with medical devices and chronic infections. The paper provides an in-depth analysis of several studies that highlight how EOs, through their diverse chemical compositions, possess the ability to disrupt biofilm formation by bacteria and fungi.
Who was reviewed
The review analyzed various scientific literature and research papers that evaluated the effectiveness of essential oils in combating microbial biofilms. The focus was on assessing how different essential oils have antimicrobial properties that can disrupt biofilm formation and enhance the effectiveness of traditional treatments.
What were the most important findings?
The most important finding of this review is the significant role essential oils (EOs) can play in combating microbial biofilms, which are highly resistant to conventional antibiotics. The review outlines various essential oils, such as those derived from Melaleuca alternifolia (tea tree oil), Lavandula angustifolia (lavender oil), and Cinnamomum zeylanicum (cinnamon oil), that have been proven to inhibit or eradicate biofilms. Specifically, the antimicrobial components of EOs, including terpenes and terpenoids, act by permeabilizing bacterial membranes, which makes biofilms more susceptible to antimicrobial treatments. The review emphasizes that these oils not only affect planktonic bacteria but also disrupt biofilms formed on surfaces, which is crucial in the context of medical devices like catheters and prosthetics.
In terms of microbial associations, the review focuses on EOs’ efficacy against a range of pathogenic organisms, including Staphylococcus aureus, Escherichia coli, and Candida species. Biofilms formed by these organisms on medical devices are notably resistant to conventional treatments, and the use of EOs could offer a complementary or alternative approach. The synergistic effect of combining EOs with traditional antibiotics is also highlighted, as this combination increases the efficacy of treatment and reduces the chances of biofilm formation.
What are the implications of this review?
The review reveals the potential of essential oils as a safe and effective alternative to conventional antibiofilm agents, particularly for infections related to medical devices, foodborne illnesses, and oral health. The diverse chemical compositions of EOs reduce the likelihood of microbial resistance, a growing concern with traditional antibiotics. Furthermore, the combination of EOs with other antimicrobial treatments offers promising results for tackling biofilm-related infections more effectively. The study suggests that further clinical trials and the optimization of EO formulations are needed to fully harness their potential in combating biofilms, especially in medical and industrial applications. Incorporating EO-based therapies into current infection control practices could help address the persistent problem of biofilm-associated infections, which are difficult to treat with traditional antibiotics alone.